- Report
- April 2025
- 50 Pages
Global
From €2502EUR$2,650USD£2,146GBP
Nikethamide is a respiratory drug used to treat a variety of conditions, including asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it helps to open up the airways and make breathing easier. It is available in both oral and injectable forms, and is often used in combination with other medications. It is also used to treat acute episodes of breathlessness, such as those caused by exercise or an asthma attack.
The Nikethamide market is a growing sector of the respiratory drug industry. It is used to treat a wide range of conditions, and is increasingly being prescribed as a first-line treatment for asthma and COPD. It is also used in combination with other drugs to treat more severe cases.
Companies in the Nikethamide market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. These companies produce both oral and injectable forms of the drug, and are actively researching new formulations and applications. Show Less Read more